Lipoprotein(a): An Emerging Therapeutic Target

Saturday, February 25, 2023

4:14 PM – 4:22 PM ET

Speaker(s)

Robert S. Rosenson, MD

Director of Metabolism and Lipids
Mount Sinai Health System
New York, New York, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Arrowhead: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CRISPR Theraptucis: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Kowa Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Precision BioSciences: Consultant/Advisory Board (Ongoing); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing); Verve Therapeutics: Consultant (Ongoing); Wolters Kluwer Health: Royalties (Ongoing)

Disclosure(s):

Robert S. Rosenson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Arrowhead: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CRISPR Theraptucis: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Kowa Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Precision BioSciences: Consultant/Advisory Board (Ongoing); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing); Verve Therapeutics: Consultant (Ongoing); Wolters Kluwer Health: Royalties (Ongoing)